BTC Capital Management’s Biogen BIIB Stock Holding History

BTC Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-708	Closed	-$233K	–	140
2014 Q3	$233K	Buy	+708	New	+$233K	0.06%	128

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BTC Capital Management's BIIB Position: Q4 2014 in Review

BTC Capital Management sold out of Biogen (BIIB) in Q4 2014, closing a stake of 708 shares — an estimated $233K sold.

BTC Capital Management first reported a position in BIIB in Q3 2014 and held it in 1 quarter. The position peaked at $233K in Q3 2014. 885 funds tracked by Wall St. Rank hold BIIB as of Q4 2014.

BTC Capital Management reported no remaining Biogen position as of Q4 2014 after selling out during the quarter.
BTC Capital Management sold 708 Biogen shares in Q4 2014, an estimated $233K.
BTC Capital Management first reported a position in Biogen in Q3 2014 and held it in 1 quarter.
BTC Capital Management's Biogen position peaked at $233K in Q3 2014.
885 funds tracked by Wall St. Rank held Biogen as of Q4 2014.

Based on BTC Capital Management's 13F filing for Q4 2014, filed 11 Feb 2015.